Since the May 2022 Mpox outbreak began, people have been lining up to receive a smallpox vaccine authorized by the U.S. Food and Drug Administration (FDA).
Since then, numerous studies have been conducted to quantify if Bavarian Nordic's JYNNEOS® (MVA-BN) vaccine is effective in reducing virus transmission or hospitalizations against the mpox West African clade IIb subtype.
Read More
